| Product Code: ETC6748136 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Myasthenia Gravis Disease Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Myasthenia Gravis Disease Market Revenues & Volume, 2021 & 2031F |
3.3 China Myasthenia Gravis Disease Market - Industry Life Cycle |
3.4 China Myasthenia Gravis Disease Market - Porter's Five Forces |
3.5 China Myasthenia Gravis Disease Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 China Myasthenia Gravis Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 China Myasthenia Gravis Disease Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 China Myasthenia Gravis Disease Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.9 China Myasthenia Gravis Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Myasthenia Gravis Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of myasthenia gravis disease in China |
4.2.2 Growing awareness and diagnosis rates of the disease |
4.2.3 Advancements in medical technology and treatment options |
4.3 Market Restraints |
4.3.1 High treatment costs associated with managing myasthenia gravis |
4.3.2 Limited accessibility to specialized healthcare services in certain regions of China |
4.3.3 Stringent regulatory requirements for approval of new treatments |
5 China Myasthenia Gravis Disease Market Trends |
6 China Myasthenia Gravis Disease Market, By Types |
6.1 China Myasthenia Gravis Disease Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 China Myasthenia Gravis Disease Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 China Myasthenia Gravis Disease Market Revenues & Volume, By Edrophonium Test, 2021- 2031F |
6.1.4 China Myasthenia Gravis Disease Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.1.5 China Myasthenia Gravis Disease Market Revenues & Volume, By Repetitive Nerve Stimulation, 2021- 2031F |
6.1.6 China Myasthenia Gravis Disease Market Revenues & Volume, By Single-fiber electromyography (EMG), 2021- 2031F |
6.1.7 China Myasthenia Gravis Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Myasthenia Gravis Disease Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 China Myasthenia Gravis Disease Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F |
6.2.3 China Myasthenia Gravis Disease Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.2.4 China Myasthenia Gravis Disease Market Revenues & Volume, By Immunosuppressants, 2021- 2031F |
6.2.5 China Myasthenia Gravis Disease Market Revenues & Volume, By Plasmapheresis, 2021- 2031F |
6.2.6 China Myasthenia Gravis Disease Market Revenues & Volume, By Autologous Hematopoietic Stem Cell Transplantation (HSCT), 2021- 2031F |
6.2.7 China Myasthenia Gravis Disease Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3 China Myasthenia Gravis Disease Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 China Myasthenia Gravis Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 China Myasthenia Gravis Disease Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 China Myasthenia Gravis Disease Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 China Myasthenia Gravis Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 China Myasthenia Gravis Disease Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 China Myasthenia Gravis Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 China Myasthenia Gravis Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Myasthenia Gravis Disease Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 China Myasthenia Gravis Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 China Myasthenia Gravis Disease Market Revenues & Volume, By Onlin Pharmacy, 2021- 2031F |
6.5.4 China Myasthenia Gravis Disease Market Revenues & Volume, By Retail Phrmacy, 2021- 2031F |
7 China Myasthenia Gravis Disease Market Import-Export Trade Statistics |
7.1 China Myasthenia Gravis Disease Market Export to Major Countries |
7.2 China Myasthenia Gravis Disease Market Imports from Major Countries |
8 China Myasthenia Gravis Disease Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis |
8.2 Number of healthcare facilities offering specialized care for myasthenia gravis |
8.3 Patient adherence to prescribed treatment regimens |
9 China Myasthenia Gravis Disease Market - Opportunity Assessment |
9.1 China Myasthenia Gravis Disease Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 China Myasthenia Gravis Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 China Myasthenia Gravis Disease Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 China Myasthenia Gravis Disease Market Opportunity Assessment, By End users, 2021 & 2031F |
9.5 China Myasthenia Gravis Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Myasthenia Gravis Disease Market - Competitive Landscape |
10.1 China Myasthenia Gravis Disease Market Revenue Share, By Companies, 2024 |
10.2 China Myasthenia Gravis Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here